Cross Track Symposium 2 - Viral Hepatitis in Correctional Settings
| Tuesday, August 14, 2018 |
| 11:30 AM - 1:00 PM |
| Hall M (Ground Floor) |
Details
Learning Objectives - Attendees will become familiarised with HCV transmission and care delivery challenges, including facilitators and barriers to HCV treatment uptake within the prison setting (LL - social), novel HCV models of care (ET – clinical; LM - clinical), and HCV transmission and risk behaviours (BH – epi). They will also become familiarised with HBV epidemiology, prevention and clinical care within prisons in the NT (where HBV prevalence is highest among the prisoner population) (CM – HBV)
Speaker
Professor Carla Treloar
Scientia Professor, Centre for Social Research in Health and the Social Policy Research Centre
UNSW Sydney
The role of Corrective Services and Justice Health staff in promoting HCV treatment uptake among the prisoner population in NSW correctional centres
11:30 AM - 11:40 AMBiography
Professor Carla Treloar is Director of the Centre for Social Research in Health and the Social Policy Research Centre at UNSW, Sydney.
Dr Edmund Tse
Head Of Hepatology
Royal Adelaide Hospital - Liver Clinic
HealthELink, online model of HCV treatment within South Australian prisons
11:40 AM - 11:50 AMBiography
Eddie Tse is a senior Hepatologist and liver transplant physician at the Royal Adelaide Hospital (RAH). He has also completed his Doctor of Philosophy (Ph.D.) in Hepatitis C. He is the primary Hepatology specialist for the South Australian Prison Network for management of Hepatitis C infection.
A/Prof Behzad Hajarizadeh
Associate Professor
The Kirby Institute, UNSW
HCV Transmission and Risk Behaviour in NSW Prisons
11:50 AM - 12:00 PMBiography
Behzad Hajari is a clinical epidemiologist, a Senior Lecturer in the Kirby Institute (UNSW Sydney) and an NHMRC fellow. He trained as a Medical Practitioner and has an MPH and PhD in Medicine. His research interests include HCV natural history, and HCV care in prison setting and among people who inject drugs.
Ms Anne Craigie
Nurse Practitioner
St Vincent’s Hospital Melbourne
Nurse-led model of HCV care and treatment in VIC prisons
12:00 PM - 12:10 PMBiography
Hepatology Clinical Nurse Consultant with the Statewide Hepatitis Program in Victoria, Department of Gastroenterology, St Vincent’s Hospital, Melbourne.
I have extensive nursing experience in the Victorian Prison system alongside a varied acute and community nursing background. Working exclusively with a population of people greatly affected by disadvantage is professionally and personally rewarding.
Associate Professor Jane Davies
Principal Research Fellow
Menzies School Of Health Research
HBV prevalence, prevention, and treatment in NT prisons
12:10 PM - 12:20 PMBiography
Dr Jane Davies
MBBS MRCP(UK) DTM&H FRACP PhD
Dr Jane Davies is a NHMRC clinical research fellow at the Menzies School of Health Research and an Infectious Diseases and General Medicine Specialist at the Royal Darwin Hospital. Her research focuses on Hepatitis B spanning molecular and clinical epidemiology as well as translation and implementation of holistic and sustainable clinical care.
Panel Discussion
Facilitator: Andrew Lloyd. Panellist: Mark Stoove, Carla Treloar, Edmund Tse, Behzad Hajari, Jane Davies, Anne Craigie, Michael Ninburg, Shannon Wright, Michael Levy
12:20 PM - 1:00 PMBrief Overview
• Do prison settings provide opportunities or challenges for HCV elimination in the community?
• Is any of existing HCV models of care effective and feasible enough to be utilised in the national level?
• What is the role of HCV prevention strategies in the Australian prisons in DAA era when there is unrestricted access to an effective cure? (role of harm reduction and reinfection)
What are the existing challenges in delivering HBV vaccination and treatment in the prison settings?
• Is any of existing HCV models of care effective and feasible enough to be utilised in the national level?
• What is the role of HCV prevention strategies in the Australian prisons in DAA era when there is unrestricted access to an effective cure? (role of harm reduction and reinfection)
What are the existing challenges in delivering HBV vaccination and treatment in the prison settings?
Biography
Chair
Andrew Lloyd
Head, Viral Immunology Systems Program
UNSW Sydney
Mark Stoove
Head, Public Health Discipline, Co-Head of the HIV Elimination Program
Burnet Institute
